BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 36889779)

  • 1. RNF43 Suppressed Triple-Negative Breast Cancer Progression by Inhibiting Wnt/beta-Catenin Pathway.
    Zhu L; Shi H; Li P; Zhang P
    Ann Clin Lab Sci; 2023 Jan; 53(1):21-29. PubMed ID: 36889779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-125b regulates the proliferation and metastasis of triple negative breast cancer cells via the Wnt/β-catenin pathway and EMT.
    Nie J; Jiang HC; Zhou YC; Jiang B; He WJ; Wang YF; Dong J
    Biosci Biotechnol Biochem; 2019 Jun; 83(6):1062-1071. PubMed ID: 30950326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The natural compound Jatrophone interferes with Wnt/β-catenin signaling and inhibits proliferation and EMT in human triple-negative breast cancer.
    Fatima I; El-Ayachi I; Taotao L; Lillo MA; Krutilina RI; Seagroves TN; Radaszkiewicz TW; Hutnan M; Bryja V; Krum SA; Rivas F; Miranda-Carboni GA
    PLoS One; 2017; 12(12):e0189864. PubMed ID: 29281678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CircRNA_069718 promotes cell proliferation and invasion in triple-negative breast cancer by activating Wnt/β-catenin pathway.
    Zhang J; Xu HD; Xing XJ; Liang ZT; Xia ZH; Zhao Y
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5315-5322. PubMed ID: 31298383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-cell transcriptomics reveals the intra-tumoral heterogeneity and SQSTM1/P62 and Wnt/β-catenin mediated epithelial to mesenchymal transition and stemness of triple-negative breast cancer.
    Shome R; Sen P; Sarkar S; Ghosh SS
    Exp Cell Res; 2024 May; 438(1):114032. PubMed ID: 38583856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinesin family member 23, regulated by FOXM1, promotes triple negative breast cancer progression via activating Wnt/β-catenin pathway.
    Li Z; Yang HY; Zhang XL; Zhang X; Huang YZ; Dai XY; Shi L; Zhou GR; Wei JF; Ding Q
    J Exp Clin Cancer Res; 2022 May; 41(1):168. PubMed ID: 35524313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor-associated macrophages promote epithelial-mesenchymal transition and the cancer stem cell properties in triple-negative breast cancer through CCL2/AKT/β-catenin signaling.
    Chen X; Yang M; Yin J; Li P; Zeng S; Zheng G; He Z; Liu H; Wang Q; Zhang F; Chen D
    Cell Commun Signal; 2022 Jun; 20(1):92. PubMed ID: 35715860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Silencing of Prrx1b suppresses cellular proliferation, migration, invasion and epithelial-mesenchymal transition in triple-negative breast cancer.
    Lv ZD; Yang ZC; Liu XP; Jin LY; Dong Q; Qu HL; Li FN; Kong B; Sun J; Zhao JJ; Wang HB
    J Cell Mol Med; 2016 Sep; 20(9):1640-50. PubMed ID: 27027510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sesamol inhibits proliferation, migration and invasion of triple negative breast cancer via inactivating Wnt/β-catenin signaling.
    Ma X; Hu X; Zhu Y; Jin H; Hu G; Ding L; Ning S
    Biochem Pharmacol; 2022 Dec; 206():115299. PubMed ID: 36244446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FAM96A and FAM96B function as new tumor suppressor genes in breast cancer through regulation of the Wnt/β-catenin signaling pathway.
    Zhang DD; Sun XL; Liang ZY; Wang XY; Zhang LN
    Life Sci; 2022 Nov; 308():120983. PubMed ID: 36165859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-6838-5p suppresses cell metastasis and the EMT process in triple-negative breast cancer by targeting WNT3A to inhibit the Wnt pathway.
    Liu G; Wang P; Zhang H
    J Gene Med; 2019 Dec; 21(12):e3129. PubMed ID: 31693779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-296-3p inhibits cell proliferation by the SOX4-Wnt/βcatenin pathway in triple-negative breast cancer.
    Tian D; Luo L; Wang T; Qiao J
    J Biosci; 2021; 46():. PubMed ID: 34785625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of endoplasmic reticulum stress alleviates triple-negative breast cancer cell viability, migration, and invasion by Syntenin/SOX4/Wnt/β-catenin pathway via regulation of heat shock protein A4.
    Nan J; Hu X; Guo B; Xu M; Yao Y
    Bioengineered; 2022 Apr; 13(4):10564-10577. PubMed ID: 35442158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer-Associated Fibroblasts Autophagy Enhances Progression of Triple-Negative Breast Cancer Cells.
    Wang M; Zhang J; Huang Y; Ji S; Shao G; Feng S; Chen D; Zhao K; Wang Z; Wu A
    Med Sci Monit; 2017 Aug; 23():3904-3912. PubMed ID: 28802099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HePTP promotes migration and invasion in triple-negative breast cancer cells via activation of Wnt/β-catenin signaling.
    Yu L; Wang C; Pan F; Liu Y; Ren X; Zeng H; Shi Y
    Biomed Pharmacother; 2019 Oct; 118():109361. PubMed ID: 31545274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coordinated regulation of WNT/β-catenin, c-Met, and integrin signalling pathways by miR-193b controls triple negative breast cancer metastatic traits.
    Giacomelli C; Jung J; Wachter A; Ibing S; Will R; Uhlmann S; Mannsperger H; Sahin Ö; Yarden Y; Beißbarth T; Korf U; Körner C; Wiemann S
    BMC Cancer; 2021 Dec; 21(1):1296. PubMed ID: 34863149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of NuSAP1 is predictive of an unfavourable prognosis and promotes proliferation and invasion of triple-negative breast cancer cells via the Wnt/β-catenin/EMT signalling axis.
    Sun L; Shi C; Liu S; Zhang E; Yan L; Ji C; Zhao Y
    Gene; 2020 Jul; 747():144657. PubMed ID: 32298762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Profilin 2 (PFN2) promotes the proliferation, migration, invasion and epithelial-to-mesenchymal transition of triple negative breast cancer cells.
    Ling Y; Cao Q; Liu Y; Zhao J; Zhao Y; Li K; Chen Z; Du X; Huo X; Kang H; Chen Z
    Breast Cancer; 2021 Mar; 28(2):368-378. PubMed ID: 33047272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disruption of ZNF334 promotes triple-negative breast carcinoma malignancy through the SFRP1/ Wnt/β-catenin signaling axis.
    Cheng Z; Yu R; Li L; Mu J; Gong Y; Wu F; Liu Y; Zhou X; Zeng X; Wu Y; Sun R; Xiang T
    Cell Mol Life Sci; 2022 May; 79(5):280. PubMed ID: 35507080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tweaking EMT and MDR dynamics to constrain triple-negative breast cancer invasiveness by EGFR and Wnt/β-catenin signaling regulation.
    Shome R; Ghosh SS
    Cell Oncol (Dordr); 2021 Apr; 44(2):405-422. PubMed ID: 33398673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.